Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial
Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe study's recruitment status has been updated to indicate that no participants are being sought anymore. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and there is a minor formatting change to the Intervention/Treatment label along with an updated revision note (Revision: v3.6.0).SummaryDifference0.4%

- Check18 days agoChange DetectedThe Study Details page now displays the current revision tag v3.5.5, replacing the previous v3.5.4, indicating a minor update to the page's versioning.SummaryDifference0.1%

- Check39 days agoChange DetectedA new page revision v3.5.4 is added, replacing the previous v3.5.3 revision. This indicates a minor metadata update to the study page rather than substantive content changes.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, representing a minor version update to the page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page revision label was updated to Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check97 days agoChange DetectedAdded revision: v3.5.0; deleted revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.